Frequencies of the CC chemokine receptor 5 δ32 allele in various populations of defined racial background

Biomedicine and Pharmacotherapy

Volumn 51, Issue 10, 1997, Pages 469-473

  Lucotte, G ^a  

^a HÔPITAL MAISON BLANCHE   (France)

Author keywords

Allele mutation frequency; Co receptor CCR5; Deletion 32; Population comparison

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; NUCLEOTIDE;

ARTICLE; FRANCE; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEGRO; NORTH AFRICA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; VIET NAM;

EID: 0031424990     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)82328-1     Document Type: Article

References (14)

1. Murphy PM. Chemokine receptors : structure, function and role in microbial pathogenesis. Cytokine Growth Fact Rev 1996;7:147-64
2. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77
3. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5
4. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-61
5. Zimmerman PA, Buckler-White A, Alkkatib G, Spalding T, Kubofcik J, Combadière C et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in the CC chemokine receptor 5 : studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Molec Med 1997;3:23-36
6. Biti R, French R, Young J, Bennetts B, Stewart G. HIV-1 infection in an individual homozygous for CCR5 deletion allele. Nat Med 1997;3:252-3
7. O'Brien T, Winkler C, Dean M. Nelson JAE, Carrington M, Michael NL. White II GC. HIV-1 infection in a man homozygous for CCR5 Δ32. Lancet 1997;349:1219
8. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C and the Seroco Study. HIV-1 infection in an individual homozygous for CCR5 32. Lancet 1997;349:1219-20
9. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3
10. Rappaport J, Cho YY, Hendel H, Schwartz EJ, Schachter F, Zagury JF. 32 bp CCR5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet 1997;349:922-3
11. Michael NL, Chang G, Louie L, Mascola JR, Dondero D, Birx DL et al. The role of viral phenotype and CCR5 gene defect in HIV-1 transmission and progression. Nat Med 1997;3:338-40
12. Gautreau C, Rahuel C, Cartron JP, Lucotte G. Comparison of two methods of high-molecular-weight DNA isolation from human leucocytes. Anal Biochem 1983;134:320-4
13. Rahuel C, Dandieu C. Chaussé AM, Mornet E, Rouyer P, Cartron JP et al. Constitution d'une DNAthèque d'origine humaine. Rev Fr Transf Immuno-Hématol 1983;26:539-52
14. Lucotte G, Gérard N, Krishnamoorthy R, David F, Aouizérate A, Galzot P. Reduced variability in Y-chromosome-specific haplotypes for some Central African Populations. Hum Biol 1994;66:19-526